US20110190873A1 - Stent - Google Patents
Stent Download PDFInfo
- Publication number
- US20110190873A1 US20110190873A1 US13/082,681 US201113082681A US2011190873A1 US 20110190873 A1 US20110190873 A1 US 20110190873A1 US 201113082681 A US201113082681 A US 201113082681A US 2011190873 A1 US2011190873 A1 US 2011190873A1
- Authority
- US
- United States
- Prior art keywords
- strut
- stent
- segment
- pairs
- straight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91583—Adjacent bands being connected to each other by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
Definitions
- This invention relates to an endoprosthesis device for implantation within a body vessel, typically a blood vessel. More specifically, it relates to a tubular expandable stent having improved structural aspects as well as improved drug retention/delivery capabilities.
- Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices, collectively referred to hereinafter as stents, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously.
- Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc.
- Stents may be used to support body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).
- Stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled, and/or from one or more interwoven wires or braids.
- Known construction materials for use in stents include polymers, organic fabrics, and biocompatible metals.
- Metals and/or alloys of such metals that have been used in the construction of stents and/or their components include but are not limited to: stainless steel, gold, silver, tantalum, titanium, chromium, cobalt and shape memory alloys such as Nitinol.
- stents In an effort to combat vessel restenosis, as well as other medical conditions, stents have been employed to delivery a variety of therapeutic agents directly to the site of stent deployment. Some stents employ a variety of structural features, such as slots, grooves, holes, chambers, etc, to act as reservoirs for a therapeutic agent and/or other substances.
- Embodiments of the present invention are directed to stent structures, which when used for the delivery of therapeutic agents such as drugs, provide improved drug delivery characteristics.
- the unique arrangement and configuration of drug delivery reservoirs throughout the stent structure provide improved drug delivery characteristics without compromise to the stent's performance characteristics.
- Embodiments of the present invention include stents, which have improved flexibility, but also sufficient structural strength to permit the stents to traverse the tortuous confines of mammalian anatomy.
- the stent of the present invention are provided with strut bands of long and short struts, wherein pairs of short struts are connected to one another at junctions. The junctions provide a circumferential offset within the strut band.
- the stents are provided with connectors between the strut bands, which have opposingly oriented U-shaped links, wherein each link extends from a junction of adjacent strut bands.
- the combination of the structural features provided in the stents of the present invention provide a structurally improved, highly flexible stent.
- An additional goal of the present invention is to provide stents with improved drug delivery characteristics as well. This goal is achieved by providing stents with drug delivery reservoirs that are positioned in and defined by the strut band junctions, as well as the connectors, and in some cases the struts as well. In some embodiments at least some of the reservoirs are provided in circumferentially aligned columns about the stent.
- Reservoirs can be any type of surface feature suitable for containing a defined amount of therapeutic agent(s) such as a drug or drug/polymer matrix.
- one or more of the reservoirs extend only partially through the thickness of the stent with only a single opening on either the inner surface (luminal) or outer surface (abluminal) of the stent.
- one or more of the reservoirs is a through-hole which extends entirely through the thickness of the stent body.
- Each reservoir can have a constant or varied cross-sectional area throughout its thicknesses.
- Each reservoir opening can have any of a variety of sizes or shapes.
- FIG. 1 shows a flat pattern view of an embodiment of the invention.
- FIG. 2 shows a flat pattern view of an embodiment of the invention.
- FIG. 3 shows a flat pattern view of an embodiment of the invention.
- At least one embodiment of the present invention is directed to a stent 10 , an example of which is illustrated in FIG. 1 .
- the structure of stent 10 is comprised of a plurality of strut bands 20 and connectors 40 .
- Each strut band 20 forms a closed path of alternating peaks 22 and troughs 24 .
- Strut bands 20 that are adjacent one another are connected by at least one connector 40 .
- Each strut band 20 comprises a plurality of long struts 30 , a plurality of first short struts 32 and second short struts 34 , and a plurality of junctions 36 .
- Each junction 36 is positioned between and connects a first short strut 32 and a second short strut 34 .
- each first short strut 32 is longitudinally and circumferentially offset from each second short strut 34 .
- Each long strut 30 is connected to a first short strut 32 at a peak 22 and to a second short strut 34 at a trough 24 .
- each junction 36 defines a single junction reservoir 12 , wherein all of the junction reservoirs 12 of a given strut band 20 are substantially circumferentially aligned. In some embodiments however, a junction defines a plurality, such as 1, 2, 3, 4 or more junction reservoirs.
- the connectors 40 comprise a first arm 42 which extends from a junction 36 on one strut band 20 and a second arm 46 which extends from a junction 36 on an adjacent strut band 20 .
- At least a portion of the first arm 42 comprises a first U-shaped link 44 and at least a portion of the second arm 46 comprises a second U-shaped link 48 .
- Each first U-shaped link 44 opens in a first direction and each second U-shaped link 48 opens in a second direction substantially opposite the first direction.
- each link 44 and 48 opens in a substantially circumferential direction or substantially perpendicular to a longitudinal axis of the stent 10 .
- At least a portion of the first U-shaped link 44 and at least a portion of the second U-shaped link 48 have a shared portion 50 .
- the shared portion 50 of each connector 40 is disposed between one of the peaks 22 on one strut band 20 and a longitudinally adjacent trough 24 of an adjacent strut band 20 .
- the shared portions 50 between any two strut bands 20 are substantially circumferentially aligned.
- the strut bands 20 or a single continuous can be angled relative to a longitudinal axis of the stent to provide the band(s) with a helical or helical-like configuration.
- the shared portions 50 of connectors 40 between a given pair of strut bands 40 can likewise be slanted or angled relative to the longitudinal axis.
- each long strut 30 defines at least one strut reservoir 14 .
- one or more of the long struts 30 define a plurality of strut reservoirs 14 .
- the number of strut reservoirs 14 on a given long strut 30 can be varied from one to about twelve, depending on the length of the long strut 30 . In some embodiments the number of strut reservoirs 14 is between at least three to nine. In the embodiment depicted in FIG. 2 , in each long strut 30 one of the strut reservoirs 14 is in substantial circumferential alignment with the junction reservoirs 12 of a given strut band 20 .
- the additional reservoirs 14 are spaced equidistantly from one another and are distributed evenly on either side of the central reservoir in circumferential alignment with the junction reservoirs 12 .
- each long strut 30 has a long strut width, 31 and each first and second short strut 32 / 34 has a short strut width 33 .
- the long strut width 31 is greater than the short strut width 33 .
- long strut width 31 is substantially the same as the short strut width 33 .
- each arm 42 and 46 of the connectors 40 have an arm width 45 .
- the arm width is less than either the long strut width 31 or the short strut width 33 .
- the width 45 of the arms 42 and 46 can vary along their lengths, particularly if the presence of connector reservoirs 16 necessitate a greater width region 47 in order to accommodate the desired cross-sectional area of the reservoirs 16 .
- each connector 40 defines a single connector reservoir 16 .
- the cross-sectional area 51 of a given connector reservoir 16 is greater than the cross-sectional area 53 of junction reservoir 12 or the cross-sectional area 55 of a strut reservoir 14 (areas 51 , 53 , and 55 are depicted shaded).
- At least a portion of the first U-shaped link 44 , adjacent to the shared portion 50 defines at least one connector reservoir 16 and at least a portion of the second U-shaped link 48 , adjacent to the shared portion 50 , defines at least one connector reservoir 16 .
- the area 51 of each connector reservoir is less than or substantially equal to the area 53 of each junction reservoir 12 .
- first U-shaped link 44 and the second U-shaped link 48 each define a plurality of first connector reservoirs 16 a.
- a region of the first arm 42 adjacent the first U-shaped link 44 and a region of the second arm 46 adjacent the second U-shaped link 48 each define a second plurality of connector reservoirs 16 b.
- the first plurality 16 a is greater than the second plurality 16 b.
- the particular configuration and arrangement of the connector reservoirs 16 is not limited to only those configurations/patterns shown in FIGS. 1-3 .
- the distribution, size, shape and configuration of the connector reservoirs (as well as the junction reservoirs and strut reservoirs) can be modified, in order to provide desired distribution/elution characteristics of one or more drugs or other therapeutic agents.
- a therapeutic agent may be a drug or other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc.
- suitable non-genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc.
- an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to: DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc.
- the cellular material may include but is not limited to: cells of human origin and/or non-human origin as well as their respective components and/or derivatives thereof.
- the polymer agent may be a polystyrene-polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.
- SIBS polystyrene-polyisobutylene-polystyrene triblock copolymer
- the stent 10 shown and described herein may be made from any suitable biocompatible materials including one or more polymers, one or more metals or combinations of polymer(s) and metal(s).
- suitable materials include biodegradable materials that are also biocompatible.
- biodegradable is meant that a material will undergo breakdown or decomposition into harmless compounds as part of a normal biological process.
- Suitable biodegradable materials include polylactic acid, polyglycolic acid (PGA), collagen or other connective proteins or natural materials, polycaprolactone, hylauric acid, adhesive proteins, co-polymers of these materials as well as composites and combinations thereof and combinations of other biodegradable polymers.
- Other polymers that may be used include polyester and polycarbonate copolymers.
- suitable metals include, but are not limited to, stainless steel, titanium, tantalum, platinum, tungsten, gold and alloys of any of the above-mentioned metals.
- suitable alloys include, but are not limited to: platinum-iridium alloys, cobalt-chromium alloys, including Elgiloy and Phynox, MP35N alloy and nickel-titanium alloys, for example, Nitinol.
- the stent 10 may be made of shape memory materials such as superelastic Nitinol or spring steel, or may be made of materials which are plastically deformable. In the case of shape memory materials, the stent may be provided with a memorized shape and then deformed to a reduced diameter shape. The stent 10 may restore itself to its memorized shape upon being heated to a transition temperature and having any restraints removed therefrom.
- shape memory materials such as superelastic Nitinol or spring steel
- the stent 10 may be manufactures by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids. Any other suitable technique which is known in the art or which is subsequently developed may also be used to manufacture the stent 10 disclosed herein.
- the stent 10 may include one or more areas, bands, coatings, members, etc. that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc. In some embodiments at least a portion of the stent is at least partially radiopaque.
- any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims).
- each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims.
- the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.
Abstract
A stent with strut bands and connectors, wherein the strut bands have long and short struts with a junction positioned between the short struts. Each junction defines a reservoir, wherein the reservoirs of a strut band are substantially circumferentially aligned. The connectors each have arms, wherein each arm includes an opposing U-shaped link. The opposing links have a shared portion disposed between a peak on one strut band and a longitudinally adjacent trough of an adjacent strut band.
Description
- This Application is a continuation of U.S. patent application Ser. No. 12/783,781, Published as 2010/0222868, and filed on May 20, 2010, which is a division of U.S. patent application Ser. No. 11/960,333, filed on Dec. 19, 2007 and issued as U.S. Pat. No. 7,722,661, both of which are herein incorporated by reference.
- Not Applicable
- This invention relates to an endoprosthesis device for implantation within a body vessel, typically a blood vessel. More specifically, it relates to a tubular expandable stent having improved structural aspects as well as improved drug retention/delivery capabilities.
- Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices, collectively referred to hereinafter as stents, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc. Stents may be used to support body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).
- Stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled, and/or from one or more interwoven wires or braids.
- Known construction materials for use in stents include polymers, organic fabrics, and biocompatible metals. Metals and/or alloys of such metals that have been used in the construction of stents and/or their components include but are not limited to: stainless steel, gold, silver, tantalum, titanium, chromium, cobalt and shape memory alloys such as Nitinol.
- In an effort to combat vessel restenosis, as well as other medical conditions, stents have been employed to delivery a variety of therapeutic agents directly to the site of stent deployment. Some stents employ a variety of structural features, such as slots, grooves, holes, chambers, etc, to act as reservoirs for a therapeutic agent and/or other substances.
- There remains a need for drug delivery stents that have improved structural performance characteristics, such as improved flexibility, structural integrity, compression resistance, etc. There also remains a need to provide such stents with a more desirable drug delivery profile.
- The art referred to and/or described above is not intended to constitute an admission that any patent, publication or other information referred to herein is “prior art” with respect to this invention. In addition, this section should not be construed to mean that a search has been made or that no other pertinent information as defined in 37 C.F.R. §1.56(a) exists.
- All U.S. patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.
- Without limiting the scope of the invention a brief summary of some of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below.
- A brief abstract of the technical disclosure in the specification is provided as well only for the purposes of complying with 37 C.F.R. 1.72. The abstract is not intended to be used for interpreting the scope of the claims.
- Embodiments of the present invention are directed to stent structures, which when used for the delivery of therapeutic agents such as drugs, provide improved drug delivery characteristics. The unique arrangement and configuration of drug delivery reservoirs throughout the stent structure provide improved drug delivery characteristics without compromise to the stent's performance characteristics.
- Embodiments of the present invention include stents, which have improved flexibility, but also sufficient structural strength to permit the stents to traverse the tortuous confines of mammalian anatomy. In some embodiments the stent of the present invention are provided with strut bands of long and short struts, wherein pairs of short struts are connected to one another at junctions. The junctions provide a circumferential offset within the strut band.
- In some embodiments the stents are provided with connectors between the strut bands, which have opposingly oriented U-shaped links, wherein each link extends from a junction of adjacent strut bands.
- The combination of the structural features provided in the stents of the present invention provide a structurally improved, highly flexible stent.
- An additional goal of the present invention however, is to provide stents with improved drug delivery characteristics as well. This goal is achieved by providing stents with drug delivery reservoirs that are positioned in and defined by the strut band junctions, as well as the connectors, and in some cases the struts as well. In some embodiments at least some of the reservoirs are provided in circumferentially aligned columns about the stent.
- Reservoirs can be any type of surface feature suitable for containing a defined amount of therapeutic agent(s) such as a drug or drug/polymer matrix. In some embodiments one or more of the reservoirs extend only partially through the thickness of the stent with only a single opening on either the inner surface (luminal) or outer surface (abluminal) of the stent. In some embodiments, one or more of the reservoirs is a through-hole which extends entirely through the thickness of the stent body. Each reservoir can have a constant or varied cross-sectional area throughout its thicknesses. Each reservoir opening can have any of a variety of sizes or shapes.
- These and other embodiments which characterize the invention are pointed out with particularity in the claims annexed hereto and forming a part hereof. However, for further understanding of the invention, its advantages and objectives obtained by its use, reference can be made to the drawings which form a further part hereof and the accompanying descriptive matter, in which there is illustrated and described a embodiments of the invention.
- A detailed description of the invention is hereafter described with specific reference being made to the drawings.
-
FIG. 1 shows a flat pattern view of an embodiment of the invention. -
FIG. 2 shows a flat pattern view of an embodiment of the invention. -
FIG. 3 shows a flat pattern view of an embodiment of the invention. - While this invention may be embodied in many different forms, there are described in detail herein specific embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
- For the purposes of this disclosure, like reference numerals in the figures shall refer to like features unless otherwise indicated.
- At least one embodiment of the present invention is directed to a
stent 10, an example of which is illustrated inFIG. 1 . The structure ofstent 10 is comprised of a plurality ofstrut bands 20 andconnectors 40. - Each
strut band 20 forms a closed path ofalternating peaks 22 andtroughs 24.Strut bands 20 that are adjacent one another are connected by at least oneconnector 40. - Each
strut band 20 comprises a plurality oflong struts 30, a plurality of firstshort struts 32 and secondshort struts 34, and a plurality ofjunctions 36. Eachjunction 36 is positioned between and connects a firstshort strut 32 and a secondshort strut 34. In the embodiments depicted inFIGS. 1-3 , within eachstrut band 20 each firstshort strut 32 is longitudinally and circumferentially offset from each secondshort strut 34. Eachlong strut 30 is connected to a firstshort strut 32 at apeak 22 and to a secondshort strut 34 at atrough 24. - In the various embodiments shown in
FIGS. 1-3 eachjunction 36 defines asingle junction reservoir 12, wherein all of thejunction reservoirs 12 of a givenstrut band 20 are substantially circumferentially aligned. In some embodiments however, a junction defines a plurality, such as 1, 2, 3, 4 or more junction reservoirs. - In some embodiments, the
connectors 40 comprise afirst arm 42 which extends from ajunction 36 on onestrut band 20 and asecond arm 46 which extends from ajunction 36 on anadjacent strut band 20. At least a portion of thefirst arm 42 comprises a firstU-shaped link 44 and at least a portion of thesecond arm 46 comprises a secondU-shaped link 48. Each firstU-shaped link 44 opens in a first direction and each secondU-shaped link 48 opens in a second direction substantially opposite the first direction. Though the specific orientation of the opening of the links can be varied and in any direction, in the embodiments shown inFIG. 1-3 , eachlink stent 10. - At least a portion of the first
U-shaped link 44 and at least a portion of the secondU-shaped link 48 have a sharedportion 50. The sharedportion 50 of eachconnector 40 is disposed between one of thepeaks 22 on onestrut band 20 and a longitudinallyadjacent trough 24 of anadjacent strut band 20. In embodiments where thestent 10 includes a plurality ofconnectors 40 betweenadjacent strut bands 20, the sharedportions 50 between any twostrut bands 20 are substantially circumferentially aligned. - If desired the
strut bands 20 or a single continuous can be angled relative to a longitudinal axis of the stent to provide the band(s) with a helical or helical-like configuration. In such an embodiment the sharedportions 50 ofconnectors 40 between a given pair ofstrut bands 40 can likewise be slanted or angled relative to the longitudinal axis. - In the embodiment depicted in
FIG. 2 eachlong strut 30 defines at least onestrut reservoir 14. In some embodiments, one or more of thelong struts 30 define a plurality ofstrut reservoirs 14. The number ofstrut reservoirs 14 on a givenlong strut 30 can be varied from one to about twelve, depending on the length of thelong strut 30. In some embodiments the number ofstrut reservoirs 14 is between at least three to nine. In the embodiment depicted inFIG. 2 , in eachlong strut 30 one of thestrut reservoirs 14 is in substantial circumferential alignment with thejunction reservoirs 12 of a givenstrut band 20. Where there is a plurality ofstrut reservoirs 14 on along strut 30, preferably theadditional reservoirs 14 are spaced equidistantly from one another and are distributed evenly on either side of the central reservoir in circumferential alignment with thejunction reservoirs 12. - The various components of a stent (struts, connectors, reservoirs, etc.) can have a variety of physical characteristics, such as length, width, thickness, etc, of which each can also be varied. In the embodiments depicted in
FIG. 2 however, eachlong strut 30 has a long strut width, 31 and each first and secondshort strut 32/34 has ashort strut width 33. Thelong strut width 31 is greater than theshort strut width 33. Alternatively, in the embodiment shown inFIGS. 1 & 3 long strut width 31 is substantially the same as theshort strut width 33. - In some embodiments, such as those shown in
FIGS. 1 and 2 , eacharm connectors 40 have anarm width 45. The arm width is less than either thelong strut width 31 or theshort strut width 33. In at least one embodiment, such as is depicted inFIG. 3 , thewidth 45 of thearms connector reservoirs 16 necessitate agreater width region 47 in order to accommodate the desired cross-sectional area of thereservoirs 16. - In some embodiments, such as for example those depicted in
FIGS. 1-2 the sharedportion 50 of eachconnector 40 defines asingle connector reservoir 16. As can be seen in the illustrations, thecross-sectional area 51 of a givenconnector reservoir 16 is greater than thecross-sectional area 53 ofjunction reservoir 12 or thecross-sectional area 55 of a strut reservoir 14 (areas - In some embodiments such as in the
stent 10 depicted inFIG. 3 , at least a portion of the firstU-shaped link 44, adjacent to the sharedportion 50, defines at least oneconnector reservoir 16 and at least a portion of the secondU-shaped link 48, adjacent to the sharedportion 50, defines at least oneconnector reservoir 16. In the embodiment shown, thearea 51 of each connector reservoir is less than or substantially equal to thearea 53 of eachjunction reservoir 12. - In the embodiment depicted in
FIG. 3 the firstU-shaped link 44 and the secondU-shaped link 48 each define a plurality offirst connector reservoirs 16 a. A region of thefirst arm 42 adjacent the firstU-shaped link 44 and a region of thesecond arm 46 adjacent the secondU-shaped link 48 each define a second plurality ofconnector reservoirs 16 b. Thefirst plurality 16 a is greater than thesecond plurality 16 b. - The particular configuration and arrangement of the
connector reservoirs 16 is not limited to only those configurations/patterns shown inFIGS. 1-3 . The distribution, size, shape and configuration of the connector reservoirs (as well as the junction reservoirs and strut reservoirs) can be modified, in order to provide desired distribution/elution characteristics of one or more drugs or other therapeutic agents. - A therapeutic agent may be a drug or other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc. Some examples of suitable non-genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc. Where an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to: DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc. Where a therapeutic agent includes cellular material, the cellular material may include but is not limited to: cells of human origin and/or non-human origin as well as their respective components and/or derivatives thereof. Where the therapeutic agent includes a polymer agent, the polymer agent may be a polystyrene-polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.
- The
stent 10 shown and described herein may be made from any suitable biocompatible materials including one or more polymers, one or more metals or combinations of polymer(s) and metal(s). Examples of suitable materials include biodegradable materials that are also biocompatible. By biodegradable is meant that a material will undergo breakdown or decomposition into harmless compounds as part of a normal biological process. Suitable biodegradable materials include polylactic acid, polyglycolic acid (PGA), collagen or other connective proteins or natural materials, polycaprolactone, hylauric acid, adhesive proteins, co-polymers of these materials as well as composites and combinations thereof and combinations of other biodegradable polymers. Other polymers that may be used include polyester and polycarbonate copolymers. Examples of suitable metals include, but are not limited to, stainless steel, titanium, tantalum, platinum, tungsten, gold and alloys of any of the above-mentioned metals. Examples of suitable alloys include, but are not limited to: platinum-iridium alloys, cobalt-chromium alloys, including Elgiloy and Phynox, MP35N alloy and nickel-titanium alloys, for example, Nitinol. - The
stent 10 may be made of shape memory materials such as superelastic Nitinol or spring steel, or may be made of materials which are plastically deformable. In the case of shape memory materials, the stent may be provided with a memorized shape and then deformed to a reduced diameter shape. Thestent 10 may restore itself to its memorized shape upon being heated to a transition temperature and having any restraints removed therefrom. - The
stent 10 may be manufactures by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids. Any other suitable technique which is known in the art or which is subsequently developed may also be used to manufacture thestent 10 disclosed herein. - In some embodiments the
stent 10, or its delivery system, may include one or more areas, bands, coatings, members, etc. that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc. In some embodiments at least a portion of the stent is at least partially radiopaque. - The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. The various elements shown in the individual figures and described above may be combined or modified for combination as desired. All these alternatives and variations are intended to be included within the scope of the claims where the term “comprising” means “including, but not limited to”.
- Further, the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims. For instance, for purposes of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.
- This completes the description of the invention. Those skilled in the art may recognize other equivalents to the specific embodiment described herein which equivalents are intended to be encompassed by the claims attached hereto.
Claims (13)
1. A stent comprising:
a cylindrical body comprising a plurality of strut pairs having a first lateral side and a second lateral side, the first lateral side comprising a first straight strut segment and the second lateral side comprising a second straight strut segment, the first straight strut segment being circumferentially offset from the second straight strut segment; and
a plurality of connectors, the connectors connecting longitudinally adjacent strut pairs one to another, wherein the connectors have a first end and a second end, the first end being connected to the first straight strut segment and the second end being connected to the first straight strut segment of a longitudinally adjacent strut pair, the first end being longitudinally and circumferentially offset from the second end;
the first straight strut segment and the second straight strut segment each comprise at least one reservoir, the first straight strut segments having a different number of reservoirs than the second straight strut segments and the reservoirs having therein a therapeutic agent;
wherein the strut pairs include first strut pairs and second strut pairs, first strut pairs being longitudinally offset from second strut pairs, first lateral sides of the first strut pairs being circumferentially aligned with second lateral sides of second strut pairs.
2. The stent of claim 1 , wherein the connectors have a connector width that is less than the width of the first straight strut segment.
3. The stent of claim 1 , wherein the therapeutic agent includes a polymeric material and a drug.
4. The stent of claim 1 , wherein the second straight strut segment has between one and twelve reservoirs.
5. The stent of claim 1 , wherein the stent is metallic.
6. The stent of claim 1 , wherein the connectors comprise at least one curved portion.
7. The stent of claim 1 , wherein the first straight strut segment is connected to the second straight strut segment via a curved segment.
8. The stent of claim 7 , wherein circumferentially adjacent strut pairs are connected to one another via a curved segment.
9. The stent of claim 1 , wherein the at least one band comprises a serpentine pattern.
10. A stent comprising:
a band comprising a plurality of strut pairs having a first strut segment and a second strut segment, the first strut segments being circumferentially offset from the second strut segments;
a plurality of connectors, the connectors connecting longitudinally adjacent strut pairs to one another, wherein the connectors have first ends and second ends, the first ends being connected to a first strut segment and the second ends being connected to a first strut segment, the first end being contralateral to the second end;
wherein the first strut segment and the second strut segment each comprise at least one reservoir, the first strut segments having a different number of reservoirs than the second strut segments and the reservoirs having therein a therapeutic agent.
11. The stent of claim 10 , the strut pairs comprise first strut pairs and second strut pairs, the first strut pairs being longitudinally offset from the second strut pairs, wherein each of the first and second strut pairs comprises a first lateral side and a second lateral side, the first lateral side of the first strut pair being circumferentially aligned with the second lateral side of the longitudinally adjacent second strut pair.
12. The stent of claim 11 , wherein the stent is metallic.
13. The stent of claim 10 , wherein the band is helical.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/082,681 US20110190873A1 (en) | 2007-12-19 | 2011-04-08 | Stent |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/960,333 US7722661B2 (en) | 2007-12-19 | 2007-12-19 | Stent |
US12/783,781 US7922756B2 (en) | 2007-12-19 | 2010-05-20 | Stent |
US13/082,681 US20110190873A1 (en) | 2007-12-19 | 2011-04-08 | Stent |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/783,781 Continuation US7922756B2 (en) | 2007-12-19 | 2010-05-20 | Stent |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110190873A1 true US20110190873A1 (en) | 2011-08-04 |
Family
ID=40262667
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/960,333 Expired - Fee Related US7722661B2 (en) | 2007-12-19 | 2007-12-19 | Stent |
US12/783,781 Expired - Fee Related US7922756B2 (en) | 2007-12-19 | 2010-05-20 | Stent |
US13/082,681 Abandoned US20110190873A1 (en) | 2007-12-19 | 2011-04-08 | Stent |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/960,333 Expired - Fee Related US7722661B2 (en) | 2007-12-19 | 2007-12-19 | Stent |
US12/783,781 Expired - Fee Related US7922756B2 (en) | 2007-12-19 | 2010-05-20 | Stent |
Country Status (7)
Country | Link |
---|---|
US (3) | US7722661B2 (en) |
EP (1) | EP2231079B1 (en) |
JP (1) | JP2011507604A (en) |
CN (1) | CN101902993A (en) |
AT (1) | ATE550000T1 (en) |
CA (1) | CA2708619A1 (en) |
WO (1) | WO2009079132A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120029622A1 (en) * | 2010-08-02 | 2012-02-02 | Baillargeon Brian P | Flexible helical stent having different helical regions |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040267349A1 (en) | 2003-06-27 | 2004-12-30 | Kobi Richter | Amorphous metal alloy medical devices |
US8382821B2 (en) | 1998-12-03 | 2013-02-26 | Medinol Ltd. | Helical hybrid stent |
US20070219642A1 (en) * | 1998-12-03 | 2007-09-20 | Jacob Richter | Hybrid stent having a fiber or wire backbone |
US7169178B1 (en) * | 2002-11-12 | 2007-01-30 | Advanced Cardiovascular Systems, Inc. | Stent with drug coating |
US9039755B2 (en) | 2003-06-27 | 2015-05-26 | Medinol Ltd. | Helical hybrid stent |
US9155639B2 (en) * | 2009-04-22 | 2015-10-13 | Medinol Ltd. | Helical hybrid stent |
US20060127443A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
WO2008002778A2 (en) | 2006-06-29 | 2008-01-03 | Boston Scientific Limited | Medical devices with selective coating |
WO2008033711A2 (en) | 2006-09-14 | 2008-03-20 | Boston Scientific Limited | Medical devices with drug-eluting coating |
US20080294236A1 (en) * | 2007-05-23 | 2008-11-27 | Boston Scientific Scimed, Inc. | Endoprosthesis with Select Ceramic and Polymer Coatings |
US8431149B2 (en) * | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
JP2010533563A (en) * | 2007-07-19 | 2010-10-28 | ボストン サイエンティフィック リミテッド | Endoprosthesis with adsorption inhibiting surface |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
JP2010535541A (en) | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | Coating for medical devices with large surface area |
US20090118818A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with coating |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20090118821A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with porous reservoir and non-polymer diffusion layer |
US20090118812A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7722661B2 (en) * | 2007-12-19 | 2010-05-25 | Boston Scientific Scimed, Inc. | Stent |
JP5581311B2 (en) | 2008-04-22 | 2014-08-27 | ボストン サイエンティフィック サイムド,インコーポレイテッド | MEDICAL DEVICE HAVING INORGANIC MATERIAL COATING AND MANUFACTURING METHOD THEREOF |
WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US8114151B2 (en) * | 2008-05-08 | 2012-02-14 | Boston Scientific Scimed, Inc. | Stent with tabs and holes for drug delivery |
WO2009155328A2 (en) | 2008-06-18 | 2009-12-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
CN101732114B (en) * | 2008-11-04 | 2014-07-30 | 上海微创医疗器械(集团)有限公司 | Coronary artery stent with medicine carrying grooves |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
BRPI1008073A2 (en) | 2009-02-02 | 2016-03-15 | Cordis Corp | flexible stent design |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
WO2011056981A2 (en) | 2009-11-04 | 2011-05-12 | Nitinol Devices And Components, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
US8864811B2 (en) | 2010-06-08 | 2014-10-21 | Veniti, Inc. | Bi-directional stent delivery system |
US9301864B2 (en) | 2010-06-08 | 2016-04-05 | Veniti, Inc. | Bi-directional stent delivery system |
US9155644B2 (en) * | 2010-08-02 | 2015-10-13 | Cordis Corporation | Flexible helical stent having intermediate structural feature |
JP5902163B2 (en) * | 2010-08-02 | 2016-04-13 | コーディス・コーポレイションCordis Corporation | Flexible helical stent with intermediate structural features |
US10231855B2 (en) * | 2010-08-02 | 2019-03-19 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Flexible helical stent having intermediate non-helical region |
US9233014B2 (en) | 2010-09-24 | 2016-01-12 | Veniti, Inc. | Stent with support braces |
WO2012047308A1 (en) | 2010-10-08 | 2012-04-12 | Nitinol Devices And Components, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
CA2823535A1 (en) * | 2011-03-03 | 2012-09-07 | Boston Scientific Scimed, Inc. | Low strain high strength stent |
WO2012125184A1 (en) * | 2011-03-16 | 2012-09-20 | Boston Scientific Scimed, Inc. | Stent and delivery system |
CA3081285C (en) | 2012-05-14 | 2022-05-31 | C.R. Bard, Inc. | Uniformly expandable stent |
US20140121750A1 (en) * | 2012-10-31 | 2014-05-01 | Cook Medical Technologies Llc | Fixation Process For Nesting Stents |
USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
US10271975B2 (en) | 2013-03-15 | 2019-04-30 | Atrium Medical Corporation | Stent device having reduced foreshortening and recoil and method of making same |
WO2015007435A1 (en) * | 2013-07-19 | 2015-01-22 | Biotronik Ag | Stent |
US10835398B2 (en) | 2017-11-03 | 2020-11-17 | Covidien Lp | Meshes and devices for treating vascular defects |
Citations (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5133732A (en) * | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US5139480A (en) * | 1990-08-22 | 1992-08-18 | Biotech Laboratories, Inc. | Necking stents |
US5183085A (en) * | 1991-09-27 | 1993-02-02 | Hans Timmermans | Method and apparatus for compressing a stent prior to insertion |
US5195984A (en) * | 1988-10-04 | 1993-03-23 | Expandable Grafts Partnership | Expandable intraluminal graft |
US5242399A (en) * | 1990-04-25 | 1993-09-07 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5314444A (en) * | 1987-03-13 | 1994-05-24 | Cook Incorporated | Endovascular stent and delivery system |
US5421955A (en) * | 1991-10-28 | 1995-06-06 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5425739A (en) * | 1989-03-09 | 1995-06-20 | Avatar Design And Development, Inc. | Anastomosis stent and stent selection system |
US5441515A (en) * | 1993-04-23 | 1995-08-15 | Advanced Cardiovascular Systems, Inc. | Ratcheting stent |
US5443477A (en) * | 1994-02-10 | 1995-08-22 | Stentco, Inc. | Apparatus and method for deployment of radially expandable stents by a mechanical linkage |
US5494029A (en) * | 1992-09-29 | 1996-02-27 | Hood Laboratories | Laryngeal stents |
US5496277A (en) * | 1990-04-12 | 1996-03-05 | Schneider (Usa) Inc. | Radially expandable body implantable device |
US5507771A (en) * | 1992-06-15 | 1996-04-16 | Cook Incorporated | Stent assembly |
US5507767A (en) * | 1992-01-15 | 1996-04-16 | Cook Incorporated | Spiral stent |
US5522882A (en) * | 1994-10-21 | 1996-06-04 | Impra, Inc. | Method and apparatus for balloon expandable stent-graft delivery |
US5531741A (en) * | 1994-08-18 | 1996-07-02 | Barbacci; Josephine A. | Illuminated stents |
US5549662A (en) * | 1994-11-07 | 1996-08-27 | Scimed Life Systems, Inc. | Expandable stent using sliding members |
US5741293A (en) * | 1995-11-28 | 1998-04-21 | Wijay; Bandula | Locking stent |
US5797898A (en) * | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
US5824040A (en) * | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
US5824037A (en) * | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US5891108A (en) * | 1994-09-12 | 1999-04-06 | Cordis Corporation | Drug delivery stent |
US5902499A (en) * | 1994-05-30 | 1999-05-11 | Richerzhagen; Bernold | Method and apparatus for machining material with a liquid-guided laser beam |
US5925061A (en) * | 1997-01-13 | 1999-07-20 | Gore Enterprise Holdings, Inc. | Low profile vascular stent |
US5972027A (en) * | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
US6071305A (en) * | 1996-11-25 | 2000-06-06 | Alza Corporation | Directional drug delivery stent and method of use |
US6132461A (en) * | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
US6156062A (en) * | 1997-12-03 | 2000-12-05 | Ave Connaught | Helically wrapped interlocking stent |
US6206915B1 (en) * | 1998-09-29 | 2001-03-27 | Medtronic Ave, Inc. | Drug storing and metering stent |
US6231598B1 (en) * | 1997-09-24 | 2001-05-15 | Med Institute, Inc. | Radially expandable stent |
US6241762B1 (en) * | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US6254632B1 (en) * | 2000-09-28 | 2001-07-03 | Advanced Cardiovascular Systems, Inc. | Implantable medical device having protruding surface structures for drug delivery and cover attachment |
US6273908B1 (en) * | 1997-10-24 | 2001-08-14 | Robert Ndondo-Lay | Stents |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6355055B1 (en) * | 1995-09-01 | 2002-03-12 | Emory University | Endovascular support device and method of use |
US20020038146A1 (en) * | 1998-07-29 | 2002-03-28 | Ulf Harry | Expandable stent with relief cuts for carrying medicines and other materials |
US6379382B1 (en) * | 2000-03-13 | 2002-04-30 | Jun Yang | Stent having cover with drug delivery capability |
US6379381B1 (en) * | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
US6387124B1 (en) * | 1991-10-04 | 2002-05-14 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
US6395326B1 (en) * | 2000-05-31 | 2002-05-28 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for depositing a coating onto a surface of a prosthesis |
US6506437B1 (en) * | 2000-10-17 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device having depots formed in a surface thereof |
US6551838B2 (en) * | 2000-03-02 | 2003-04-22 | Microchips, Inc. | Microfabricated devices for the storage and selective exposure of chemicals and devices |
US6558733B1 (en) * | 2000-10-26 | 2003-05-06 | Advanced Cardiovascular Systems, Inc. | Method for etching a micropatterned microdepot prosthesis |
US20030125803A1 (en) * | 2001-11-13 | 2003-07-03 | Franco Vallana | Carrier and kit for intraluminal delivery of active principles or agents |
US6635082B1 (en) * | 2000-12-29 | 2003-10-21 | Advanced Cardiovascular Systems Inc. | Radiopaque stent |
US6656162B2 (en) * | 1999-11-17 | 2003-12-02 | Microchips, Inc. | Implantable drug delivery stents |
US6660034B1 (en) * | 2001-04-30 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Stent for increasing blood flow to ischemic tissues and a method of using the same |
US6663662B2 (en) * | 2000-12-28 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Diffusion barrier layer for implantable devices |
US6663664B1 (en) * | 2000-10-26 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with time variable radial force |
US20040024449A1 (en) * | 2000-11-17 | 2004-02-05 | Boyle Christhoper T. | Device for in vivo delivery of bioactive agents and method of manufacture thereof |
US20040034337A1 (en) * | 2002-08-16 | 2004-02-19 | Boulais Dennis R. | Microarray drug delivery coatings |
US6699281B2 (en) * | 2001-07-20 | 2004-03-02 | Sorin Biomedica Cardio S.P.A. | Angioplasty stents |
US20040044401A1 (en) * | 2002-08-30 | 2004-03-04 | Bales Thomas O. | Helical stent having improved flexibility and expandability |
US6709379B1 (en) * | 1998-11-02 | 2004-03-23 | Alcove Surfaces Gmbh | Implant with cavities containing therapeutic agents |
US6758859B1 (en) * | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
US6783543B2 (en) * | 2000-06-05 | 2004-08-31 | Scimed Life Systems, Inc. | Intravascular stent with increasing coating retaining capacity |
US6790227B2 (en) * | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US20040204750A1 (en) * | 2003-04-08 | 2004-10-14 | Medtronic Ave. | Drug-eluting stent for controlled drug delivery |
US20040254635A1 (en) * | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US6849089B2 (en) * | 2001-10-08 | 2005-02-01 | Biotronik Mess-Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin | Implant with proliferation-inhibiting substance |
US7014654B2 (en) * | 2001-11-30 | 2006-03-21 | Scimed Life Systems, Inc. | Stent designed for the delivery of therapeutic substance or other agents |
US20060224234A1 (en) * | 2001-08-29 | 2006-10-05 | Swaminathan Jayaraman | Drug eluting structurally variable stent |
US7135039B2 (en) * | 2000-03-06 | 2006-11-14 | Boston Scientific Scimed, Inc. | Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof |
US7922756B2 (en) * | 2007-12-19 | 2011-04-12 | Boston Scientific Scimed, Inc. | Stent |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
CA2308396A1 (en) | 1997-05-14 | 1998-11-19 | Novo Rps Ulc | Expandable stent and method for production of same |
US6179867B1 (en) | 1998-01-16 | 2001-01-30 | Advanced Cardiovascular Systems, Inc. | Flexible stent and method of use |
DE19916086B4 (en) | 1998-04-11 | 2004-11-11 | Inflow Dynamics Inc. | Implantable prosthesis, especially vascular prosthesis (stent) |
CN1134322C (en) | 1998-04-30 | 2004-01-14 | 辛诺瓦有限公司 | Material shaping device with laser beam which is injected into stream of liquid |
US7077859B2 (en) | 2000-12-22 | 2006-07-18 | Avantec Vascular Corporation | Apparatus and methods for variably controlled substance delivery from implanted prostheses |
WO2003055414A1 (en) | 2001-10-18 | 2003-07-10 | Advanced Stent Technologies, Inc. | Stent for vessel support, coverage and side branch accessibility |
US6828696B2 (en) | 2002-07-03 | 2004-12-07 | Fusion Uv Systems, Inc. | Apparatus and method for powering multiple magnetrons using a single power supply |
-
2007
- 2007-12-19 US US11/960,333 patent/US7722661B2/en not_active Expired - Fee Related
-
2008
- 2008-11-14 AT AT08861146T patent/ATE550000T1/en active
- 2008-11-14 JP JP2010539561A patent/JP2011507604A/en active Pending
- 2008-11-14 WO PCT/US2008/083561 patent/WO2009079132A1/en active Application Filing
- 2008-11-14 CA CA2708619A patent/CA2708619A1/en not_active Abandoned
- 2008-11-14 CN CN2008801221288A patent/CN101902993A/en active Pending
- 2008-11-14 EP EP08861146A patent/EP2231079B1/en not_active Not-in-force
-
2010
- 2010-05-20 US US12/783,781 patent/US7922756B2/en not_active Expired - Fee Related
-
2011
- 2011-04-08 US US13/082,681 patent/US20110190873A1/en not_active Abandoned
Patent Citations (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733665B1 (en) * | 1985-11-07 | 1994-01-11 | Expandable Grafts Partnership | Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5314444A (en) * | 1987-03-13 | 1994-05-24 | Cook Incorporated | Endovascular stent and delivery system |
US5133732A (en) * | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US5195984A (en) * | 1988-10-04 | 1993-03-23 | Expandable Grafts Partnership | Expandable intraluminal graft |
US5425739A (en) * | 1989-03-09 | 1995-06-20 | Avatar Design And Development, Inc. | Anastomosis stent and stent selection system |
US5496277A (en) * | 1990-04-12 | 1996-03-05 | Schneider (Usa) Inc. | Radially expandable body implantable device |
US5242399A (en) * | 1990-04-25 | 1993-09-07 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5139480A (en) * | 1990-08-22 | 1992-08-18 | Biotech Laboratories, Inc. | Necking stents |
US5183085A (en) * | 1991-09-27 | 1993-02-02 | Hans Timmermans | Method and apparatus for compressing a stent prior to insertion |
US6387124B1 (en) * | 1991-10-04 | 2002-05-14 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
US5421955A (en) * | 1991-10-28 | 1995-06-06 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5514154A (en) * | 1991-10-28 | 1996-05-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5603721A (en) * | 1991-10-28 | 1997-02-18 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5421955B1 (en) * | 1991-10-28 | 1998-01-20 | Advanced Cardiovascular System | Expandable stents and method for making same |
US5507767A (en) * | 1992-01-15 | 1996-04-16 | Cook Incorporated | Spiral stent |
US5507771A (en) * | 1992-06-15 | 1996-04-16 | Cook Incorporated | Stent assembly |
US5494029A (en) * | 1992-09-29 | 1996-02-27 | Hood Laboratories | Laryngeal stents |
US5441515A (en) * | 1993-04-23 | 1995-08-15 | Advanced Cardiovascular Systems, Inc. | Ratcheting stent |
US5443477A (en) * | 1994-02-10 | 1995-08-22 | Stentco, Inc. | Apparatus and method for deployment of radially expandable stents by a mechanical linkage |
US5902499A (en) * | 1994-05-30 | 1999-05-11 | Richerzhagen; Bernold | Method and apparatus for machining material with a liquid-guided laser beam |
US5531741A (en) * | 1994-08-18 | 1996-07-02 | Barbacci; Josephine A. | Illuminated stents |
US5891108A (en) * | 1994-09-12 | 1999-04-06 | Cordis Corporation | Drug delivery stent |
US5902266A (en) * | 1994-09-12 | 1999-05-11 | Cordis Corporation | Method for delivering a liquid solution to the interior wall surface of a vessel |
US5522882A (en) * | 1994-10-21 | 1996-06-04 | Impra, Inc. | Method and apparatus for balloon expandable stent-graft delivery |
US5549662A (en) * | 1994-11-07 | 1996-08-27 | Scimed Life Systems, Inc. | Expandable stent using sliding members |
US6355055B1 (en) * | 1995-09-01 | 2002-03-12 | Emory University | Endovascular support device and method of use |
US5824037A (en) * | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US5741293A (en) * | 1995-11-28 | 1998-04-21 | Wijay; Bandula | Locking stent |
US5824040A (en) * | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
US5797898A (en) * | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
US6071305A (en) * | 1996-11-25 | 2000-06-06 | Alza Corporation | Directional drug delivery stent and method of use |
US5925061A (en) * | 1997-01-13 | 1999-07-20 | Gore Enterprise Holdings, Inc. | Low profile vascular stent |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6231598B1 (en) * | 1997-09-24 | 2001-05-15 | Med Institute, Inc. | Radially expandable stent |
US5972027A (en) * | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
US6273908B1 (en) * | 1997-10-24 | 2001-08-14 | Robert Ndondo-Lay | Stents |
US6156062A (en) * | 1997-12-03 | 2000-12-05 | Ave Connaught | Helically wrapped interlocking stent |
US6132461A (en) * | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
US6241762B1 (en) * | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US6562065B1 (en) * | 1998-03-30 | 2003-05-13 | Conor Medsystems, Inc. | Expandable medical device with beneficial agent delivery mechanism |
US20040254635A1 (en) * | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US20020038146A1 (en) * | 1998-07-29 | 2002-03-28 | Ulf Harry | Expandable stent with relief cuts for carrying medicines and other materials |
US6206915B1 (en) * | 1998-09-29 | 2001-03-27 | Medtronic Ave, Inc. | Drug storing and metering stent |
US6709379B1 (en) * | 1998-11-02 | 2004-03-23 | Alcove Surfaces Gmbh | Implant with cavities containing therapeutic agents |
US6379381B1 (en) * | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
US6656162B2 (en) * | 1999-11-17 | 2003-12-02 | Microchips, Inc. | Implantable drug delivery stents |
US6551838B2 (en) * | 2000-03-02 | 2003-04-22 | Microchips, Inc. | Microfabricated devices for the storage and selective exposure of chemicals and devices |
US7135039B2 (en) * | 2000-03-06 | 2006-11-14 | Boston Scientific Scimed, Inc. | Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof |
US6379382B1 (en) * | 2000-03-13 | 2002-04-30 | Jun Yang | Stent having cover with drug delivery capability |
US6395326B1 (en) * | 2000-05-31 | 2002-05-28 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for depositing a coating onto a surface of a prosthesis |
US6783543B2 (en) * | 2000-06-05 | 2004-08-31 | Scimed Life Systems, Inc. | Intravascular stent with increasing coating retaining capacity |
US6254632B1 (en) * | 2000-09-28 | 2001-07-03 | Advanced Cardiovascular Systems, Inc. | Implantable medical device having protruding surface structures for drug delivery and cover attachment |
US6506437B1 (en) * | 2000-10-17 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device having depots formed in a surface thereof |
US6558733B1 (en) * | 2000-10-26 | 2003-05-06 | Advanced Cardiovascular Systems, Inc. | Method for etching a micropatterned microdepot prosthesis |
US6663664B1 (en) * | 2000-10-26 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with time variable radial force |
US6758859B1 (en) * | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
US20040024449A1 (en) * | 2000-11-17 | 2004-02-05 | Boyle Christhoper T. | Device for in vivo delivery of bioactive agents and method of manufacture thereof |
US6663662B2 (en) * | 2000-12-28 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Diffusion barrier layer for implantable devices |
US6635082B1 (en) * | 2000-12-29 | 2003-10-21 | Advanced Cardiovascular Systems Inc. | Radiopaque stent |
US6790227B2 (en) * | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US6660034B1 (en) * | 2001-04-30 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Stent for increasing blood flow to ischemic tissues and a method of using the same |
US6699281B2 (en) * | 2001-07-20 | 2004-03-02 | Sorin Biomedica Cardio S.P.A. | Angioplasty stents |
US20060224234A1 (en) * | 2001-08-29 | 2006-10-05 | Swaminathan Jayaraman | Drug eluting structurally variable stent |
US6849089B2 (en) * | 2001-10-08 | 2005-02-01 | Biotronik Mess-Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin | Implant with proliferation-inhibiting substance |
US20030125803A1 (en) * | 2001-11-13 | 2003-07-03 | Franco Vallana | Carrier and kit for intraluminal delivery of active principles or agents |
US7014654B2 (en) * | 2001-11-30 | 2006-03-21 | Scimed Life Systems, Inc. | Stent designed for the delivery of therapeutic substance or other agents |
US20040034337A1 (en) * | 2002-08-16 | 2004-02-19 | Boulais Dennis R. | Microarray drug delivery coatings |
US20040044401A1 (en) * | 2002-08-30 | 2004-03-04 | Bales Thomas O. | Helical stent having improved flexibility and expandability |
US20040204750A1 (en) * | 2003-04-08 | 2004-10-14 | Medtronic Ave. | Drug-eluting stent for controlled drug delivery |
US7922756B2 (en) * | 2007-12-19 | 2011-04-12 | Boston Scientific Scimed, Inc. | Stent |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120029622A1 (en) * | 2010-08-02 | 2012-02-02 | Baillargeon Brian P | Flexible helical stent having different helical regions |
US8961590B2 (en) * | 2010-08-02 | 2015-02-24 | Cordis Corporation | Flexible helical stent having different helical regions |
Also Published As
Publication number | Publication date |
---|---|
US7922756B2 (en) | 2011-04-12 |
US20090163991A1 (en) | 2009-06-25 |
JP2011507604A (en) | 2011-03-10 |
WO2009079132A1 (en) | 2009-06-25 |
EP2231079A1 (en) | 2010-09-29 |
EP2231079B1 (en) | 2012-03-21 |
US20100222868A1 (en) | 2010-09-02 |
US7722661B2 (en) | 2010-05-25 |
CN101902993A (en) | 2010-12-01 |
CA2708619A1 (en) | 2009-06-25 |
ATE550000T1 (en) | 2012-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7722661B2 (en) | Stent | |
EP2043567B1 (en) | Stent design with variable expansion columns along circumference | |
EP1954223B1 (en) | Stent configurations | |
US8317855B2 (en) | Crimpable and expandable side branch cell | |
US7959668B2 (en) | Bifurcated stent | |
US8211163B2 (en) | Hybrid symmetrical stent designs | |
US8414637B2 (en) | Stent | |
EP2658485B1 (en) | Stent | |
EP2086475B1 (en) | Bifurcated stent | |
US20100292777A1 (en) | Stent | |
EP1962740B1 (en) | Improved connectors for bifurcated stent | |
US20070208411A1 (en) | Bifurcated stent with surface area gradient | |
US20070208414A1 (en) | Tapered strength rings on a bifurcated stent petal | |
US20070208419A1 (en) | Bifurcation stent with uniform side branch projection | |
WO2010005613A1 (en) | Overlapping stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |